Grand Pharma Launches SIR-Spheres for Liver Cancer Treatment in China
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced the official launch of its SIR-Spheres...
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced the official launch of its SIR-Spheres...
China-based Qingdao HuaRen Pharmaceutical Co., Ltd (SHE: 300110) has announced receiving CE marks in the...
US-based Boston Scientific Corporation (NYSE: BSX) has announced the official market launch of its Expect...
The National Medical Products Administration (NMPA) approved a total of 164 medical devices for marketing...
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) announced the successful completion of a remote...
Shanghai Roche Pharmaceuticals Ltd. made headlines in March with the launch of its lung cancer...